33,329 Danaher Corporation $DHR Shares Sold by Simplify Asset Management Inc.

Simplify Asset Management Inc. decreased its position in Danaher Corporation (NYSE:DHR – Free Report) by 77.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,505 shares of the conglomerate’s stock after selling 33,329 shares during the period. Simplify Asset Management Inc.’s holdings in Danaher were worth $2,106,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in DHR. Marquette Asset Management LLC lifted its position in Danaher by 192.1% in the third quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock valued at $25,000 after purchasing an additional 73 shares during the period. N.E.W. Advisory Services LLC acquired a new position in Danaher during the 2nd quarter worth approximately $25,000. Main Street Group LTD acquired a new position in Danaher during the 1st quarter worth approximately $25,000. Field & Main Bank acquired a new position in Danaher during the 2nd quarter worth approximately $29,000. Finally, Evolution Wealth Management Inc. raised its stake in shares of Danaher by 208.0% during the 1st quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock worth $29,000 after buying an additional 104 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Trading Up 0.7%

Shares of DHR opened at $233.72 on Thursday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a current ratio of 1.63, a quick ratio of 1.29 and a debt-to-equity ratio of 0.45. The firm has a market capitalization of $164.43 billion, a P/E ratio of 38.25, a PEG ratio of 2.89 and a beta of 0.76. The firm’s 50-day moving average is $218.10 and its two-hundred day moving average is $201.81.

Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.92 by $0.19. The company had revenue of $6.55 billion during the quarter, compared to the consensus estimate of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The company’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same period last year, the firm earned $1.89 EPS. On average, research analysts predict that Danaher Corporation will post 8.59 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is presently 26.19%.

Analysts Set New Price Targets

DHR has been the subject of several recent analyst reports. UBS Group reissued a “buy” rating and issued a $260.00 price target on shares of Danaher in a report on Thursday, October 22nd. JPMorgan Chase & Co. upped their price objective on Danaher from $250.00 to $270.00 and gave the stock an “overweight” rating in a report on Thursday, October 22nd. Royal Bank Of Canada increased their price objective on Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a research report on Monday, October 5th. Morgan Stanley raised their target price on Danaher from $220.00 to $240.00 and gave the company an “overweight” rating in a report on Monday, October 12th. Finally, The Goldman Sachs Group restated a “buy” rating and set a $275.00 target price on shares of Danaher in a research report on Thursday, October 22nd. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $242.91.

Get Our Latest Report on Danaher

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.